TheSUBWAY.com Announces Investment Opinion: Over Achieving Stocks!
NOTE TO EDITORS: The Following Is An Investment Opinion Issued By
WESTON, FL -- (INTERNET WIRE) -- 06/06/02 -- Keep an eye on LAM
Pharmaceutical Corp. (OTCBB: LAMP). The company just released news
on exceeding expectations. LAMP is down from almost $6.50 and could
be a huge gainer in the short term. Other stock market standouts
include Durban Roodepoort Deep Lt. (Nasdaq: DROOY), down 8% on 7
million shares, Tellabs Inc. (Nasdaq: TLAB), down 4% on 6 million
shares after announcing industry-first technology solution, and
Conexant Systems Inc. (Nasdaq: CNXT), down 6% on 6 million shares
after announcing Bluetooth Development Alliance with Extended
The Nasdaq clung to the flat line till the final minutes of trading,
when it shot into the green for a positive close, adding to the gains
it managed in the previous session. Technology stocks were under
pressure in intra-day dealings, though, on the heels of a couple of
high-profile revenue warnings from the likes of Manugistics and Tibco
Software." Stated Peter Antipatis in TheSUBWAY.com's daily
commentary. Continued at www.TheSUBWAY.com.
All material herein was prepared by Capital Research Group, Inc. (CRG)
based upon information believed to be reliable. The information
contained herein is not guaranteed by CRG to be accurate, and should
not be considered to be all-inclusive. The companies that are
discussed in this opinion have not approved the statements made in
this opinion. This opinion contains forward-looking statements that
involve risks and uncertainties. This material is for informational
purposes only and should not be construed as an offer or solicitation
of an offer to buy or sell securities. CRG is not a licensed broker,
broker dealer, market maker, investment banker, investment advisor,
analyst or underwriter. Please consult a broker before purchasing or
selling any securities viewed on www.thesubway.com or mentioned
herein. CRG has been compensated by third party shareholders or with
cash from the company on behalf of one or more of the companies
mentioned in this opinion. (three hundred seventy five thousand lamp.
CRG will receive five hundred thousand shares of lamp if contract is
completed) CRG intends to sell its shares. CRG has sold approximately
two hundred and seventy five thousand lamp shares to date. CRG may
sell its shares for less than the target price given in this opinion.
CRG's affiliates, officers, directors and employees may also have
bought or may buy the shares discussed in this opinion and may profit
in the event those shares rise in value. Market commentary provided
by Peter Antipatis, CRD number 2955420. CRG will not advise as to
when it decides to sell and does not and will not offer any opinion
as to when others should sell; each investor must make that decision
based on his or her judgment of the market.
Contact: Charles T. Tamburello, Capital Research Group Inc
Provider ID: 02043096
Press spacebar to pause and continue. Press esc to stop.